132 related articles for article (PubMed ID: 37918373)
1. Efficacy of the Cytokine Adsorption Therapy in Patients with Severe COVID-19-Associated Pneumonia: Lesson Learned from a Prospective Observational Study.
Kusirisin P; Noppakun K; Trongtrakul K; Vongsanim S; Suteeka Y; Ophascharoensuk V; Pongsuwan K; Narongkiatikhun P; Theerakittikul T; Apaijai N; Chattipakorn SC; Chattipakorn N; Srisawat N
Blood Purif; 2024; 53(1):10-22. PubMed ID: 37918373
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of Early Additional Hemoperfusion Therapy for Severe COVID-19 Patients: A Prospective Cohort Study.
Surasit K; Srisawat N
Blood Purif; 2022; 51(11):879-888. PubMed ID: 35139519
[TBL] [Abstract][Full Text] [Related]
3. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.
Esmaeili Vardanjani A; Ronco C; Rafiei H; Golitaleb M; Pishvaei MH; Mohammadi M
Blood Purif; 2021; 50(2):257-260. PubMed ID: 32594085
[TBL] [Abstract][Full Text] [Related]
4. Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia.
Rampino T; Gregorini M; Perotti L; Ferrari F; Pattonieri EF; Grignano MA; Valente M; Garrone A; Islam T; Libetta C; Sepe V; Albertini R; Bruno R; Belliato M
Blood Purif; 2021; 50(4-5):566-571. PubMed ID: 33181508
[TBL] [Abstract][Full Text] [Related]
5. Hemoperfusion as an Adjuvant Therapy in Maintenance Hemodialysis Patients with Severe COVID-19: A Single Centre Experience.
Wardoyo EY; Sari AP; Djojo AY; Sarwono J; Mokoagow MI; Darnindro N; Nasarudin J; Epriliawati M; Manurung A; Iskandar M; Wibisana KA; Widyastuti AAA; Mardiyah R
Acta Med Indones; 2022 Jul; 54(3):444-450. PubMed ID: 36156468
[TBL] [Abstract][Full Text] [Related]
6. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin Adsorbent Therapy in Severe COVID-19 Pneumonia.
Peerapornratana S; Sirivongrangson P; Tungsanga S; Tiankanon K; Kulvichit W; Putcharoen O; Kellum JA; Srisawat N
Blood Purif; 2022; 51(1):47-54. PubMed ID: 33857940
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
9. Early Cytokine Removal in Critical COVID-19 Patients with Extracorporeal Therapies (HA-380 plus High Volume Hemofiltration) May Prevent Progression of Acute Respiratory Distress Syndrome: Case Report.
Ramírez-Guerrero G; Torres Cifuentes V; Baghetti Hernández R; Villagrán Cortés F; Rojas Doll S; Oliva Alarcón R; Lucero Córdova C; Flores Fernandez P; Garay Coloma O
Blood Purif; 2021; 50(4-5):575-577. PubMed ID: 33264786
[TBL] [Abstract][Full Text] [Related]
10. The absorbing filter Oxiris in severe coronavirus disease 2019 patients: A case series.
Zhang H; Zhu G; Yan L; Lu Y; Fang Q; Shao F
Artif Organs; 2020 Dec; 44(12):1296-1302. PubMed ID: 32779737
[TBL] [Abstract][Full Text] [Related]
11. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
12. The early start of hemoperfusion decreases the mortality rate among severe COVID-19 patients: A preliminary study.
Mikaeili H; Taghizadieh A; Nazemiyeh M; Rezaeifar P; Zununi Vahed S; Safiri S; Ardalan M; Ansarin K
Hemodial Int; 2022 Apr; 26(2):176-182. PubMed ID: 34907633
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical features and laboratory findings in critical intensive care unit patients with severe coronavirus disease-19 who underwent extracorporeal cytokine adsorption.
Yavuz T; Orhan S; Rollas K; Toksoy CK; Kazan ED; Bozkurt E; Cosgun İG; Yavasoglu F
Ther Apher Dial; 2023 Oct; 27(5):890-897. PubMed ID: 37177852
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.
Gokhale Y; Mehta R; Kulkarni U; Karnik N; Gokhale S; Sundar U; Chavan S; Kor A; Thakur S; Trivedi T; Kumar N; Baveja S; Wadal A; Kolte S; Deolankar A; Pednekar S; Kalekar L; Padiyar R; Londhe C; Darole P; Pol S; Gokhe SB; Padwal N; Pandey D; Yadav D; Joshi A; Badgujar H; Trivedi M; Shah P; Bhavsar P
BMC Infect Dis; 2021 Mar; 21(1):241. PubMed ID: 33673818
[TBL] [Abstract][Full Text] [Related]
15. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
[TBL] [Abstract][Full Text] [Related]
16. [Application of a risk stratification-based model for prediction of acute kidney injury combined with hemoperfusion in patients with sepsis: a prospective, observational, pilot study].
Feng F; Chen Y; Chen W; Yang H; Yang W; Du J; Li M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jul; 32(7):814-818. PubMed ID: 32788015
[TBL] [Abstract][Full Text] [Related]
17. Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm.
Shadvar K; Tagizadiyeh A; Gamari AA; Soleimanpour H; Mahmoodpoor A
Blood Purif; 2021; 50(3):405-407. PubMed ID: 33171470
[No Abstract] [Full Text] [Related]
18. Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column.
Huang Z; Wang SR; Yang ZL; Liu JY
Ther Apher Dial; 2013 Aug; 17(4):454-61. PubMed ID: 23931889
[TBL] [Abstract][Full Text] [Related]
19. High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.
Iglesias-Julián E; López-Veloso M; de-la-Torre-Ferrera N; Barraza-Vengoechea JC; Delgado-López PD; Colazo-Burlato M; Ubeira-Iglesias M; Montero-Baladía M; Lorenzo-Martín A; Minguito-de-la-Iglesia J; García-Muñoz JP; Sanllorente-Sebastián R; Vicente-González B; Alemán-Alemán A; Buzón-Martín L
J Autoimmun; 2020 Dec; 115():102537. PubMed ID: 32843231
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
Sinha P; Calfee CS; Cherian S; Brealey D; Cutler S; King C; Killick C; Richards O; Cheema Y; Bailey C; Reddy K; Delucchi KL; Shankar-Hari M; Gordon AC; Shyamsundar M; O'Kane CM; McAuley DF; Szakmany T
Lancet Respir Med; 2020 Dec; 8(12):1209-1218. PubMed ID: 32861275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
